Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
39.10
-0.05 (-0.13%)
At close: May 8, 2026, 4:00 PM EDT
39.86
+0.76 (1.94%)
After-hours: May 8, 2026, 7:46 PM EDT
Structure Therapeutics Employees
Structure Therapeutics had 220 employees as of December 31, 2025. The number of employees increased by 57 or 34.97% compared to the previous year.
Employees
220
Change (1Y)
57
Growth (1Y)
34.97%
Revenue / Employee
n/a
Profits / Employee
-$774,259
Market Cap
2.78B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 220 | 57 | 34.97% |
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 258 |
| Vera Therapeutics | 249 |
| Alumis | 224 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
GPCR News
- 2 days ago - Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 12 days ago - Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions - GlobeNewsWire
- 12 days ago - Canaccord starts Structure Therapeutics on oral weight loss pipeline - TheFly
- 12 days ago - Structure Therapeutics initiated with a Buy at Canaccord - TheFly
- 25 days ago - Structure Therapeutics appoints Matthew Lang as COO - TheFly
- 25 days ago - Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel - GlobeNewsWire
- 7 weeks ago - Structure Therapeutics price target lowered to $100 from $114 at H.C. Wainwright - TheFly
- 7 weeks ago - Structure’s GLP-1 pill could put company on M&A radar, Barron’s says - TheFly